Rocket


Overview
Financials
News + Filings
Key Docs
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other

Tags
Inv. presentation
Quarterly results
Appointed director

KNIGHT KNOX DEVELOPMENT CORP. Create: Alert

All | News | Filings
Date FiledTypeDescription
05/19/2020 4 Gorgas Gregory D. (Pres, CEO, CFO, Treas & Secr) has filed a Form 4 on ARTELO BIOSCIENCES, INC.
Txns: Bought 4,200 shares @ $1.2076, valued at $5.1k
Bought 1,600 warrants @ $6.4575, valued at $10.3k
05/18/2020 D Form D - Notice of Exempt Offering of Securities:
05/08/2020 DEF 14A Form DEF 14A - Other definitive proxy statements:
05/04/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
05/04/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
04/14/2020 424B5 Form 424B5 - Prospectus [Rule 424(b)(5)]:
04/13/2020 10-Q Quarterly Report for the period ended February 29, 2020
04/13/2020 EFFECT Form EFFECT - Notice of Effectiveness:
03/11/2020 8-K Quarterly results
02/14/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/14/2020 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/14/2020 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/14/2020 SC 13G Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
02/07/2020 8-K Other Events
02/04/2020 EFFECT Form EFFECT - Notice of Effectiveness:
01/14/2020 10-Q Quarterly Report for the period ended November 30, 2019
01/14/2020 8-K Quarterly results
Docs: "ARTELO BIOSCIENCES REPORTS FIRST QUARTER FISCAL YEAR 2020 FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE"
01/03/2020 SC 13G/A Alinga Capital LLC reports a 2.3% stake in Artelo Biosciences Inc.
12/18/2019 S-3/A Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
12/17/2019 10-K/A Annual Report for the period ended August 31, 2019 [amend]
12/13/2019 4 Beck John W (Director) has filed a Form 4 on ARTELO BIOSCIENCES, INC.
Txns: Granted 40,000 options to buy @ $2.65, valued at $106k
Granted 10,000 options to buy @ $2.65, valued at $26.5k
12/13/2019 3 Beck John W (Director) has filed a Form 3 on ARTELO BIOSCIENCES, INC.
12/06/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
11/25/2019 S-3/A Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
11/25/2019 S-3/A Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
11/25/2019 10-K Annual Report for the period ended August 31, 2019
11/15/2019 8-K Quarterly results
11/05/2019 4 Gorgas Gregory D. (Pres, CEO, CFO, Treas & Secr) has filed a Form 4 on ARTELO BIOSCIENCES, INC.
Txns: Bought 2,400 shares @ $2.2098, valued at $5.3k
11/01/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/29/2019 S-3 Form S-3 - Registration statement under Securities Act of 1933:
10/17/2019 4 Gorgas Gregory D. (Pres, CEO, CFO, Treas & Secr) has filed a Form 4 on ARTELO BIOSCIENCES, INC.
Txns: Bought 2,600 shares @ $2.051, valued at $5.3k
10/11/2019 4 Gorgas Gregory D. (Pres, CEO, CFO, Treas & Secr) has filed a Form 4 on ARTELO BIOSCIENCES, INC.
Txns: Bought 2,700 shares @ $1.9613, valued at $5.3k
09/06/2019 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
08/30/2019 4 Kelly Steven (Director) has filed a Form 4 on ARTELO BIOSCIENCES, INC.
Txns: Granted 22,250 options to buy @ $1.99, valued at $44.3k
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy